OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
High priced biologics may have a bright future in emerging markets, but winning access in the short term will be a hard sell.
Future savings from specialty pharmacies will come at pharma companies' expense.